tiprankstipranks
Dermapharm Holding SE (CH:DMP)
:DMP
Switzerland Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports

Dermapharm Holding SE (DMP) Financial Statements

0 Followers

Dermapharm Holding SE Financial Overview

Dermapharm Holding SE's market cap is currently CHF2.13B. The company's EPS TTM is CHF2.69; its P/E ratio is 17.73; Dermapharm Holding SE is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is CHF―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue€ 1.16B€ 1.18B€ 1.14B€ 1.02B€ 942.91M
Gross Profit€ 391.71M€ 767.07M€ 719.16M€ 660.83M€ 620.69M
Operating Income€ 221.75M€ 216.93M€ 182.89M€ 243.69M€ 298.47M
EBITDA€ 314.31M€ 320.91M€ 265.55M€ 329.81M€ 358.10M
Net Income€ 132.41M€ 113.79M€ 62.37M€ 134.24M€ 209.58M
Balance Sheet
Cash & Short-Term Investments€ 203.41M€ 121.71M€ 159.54M€ 161.36M€ 172.06M
Total Assets€ 2.20B€ 2.08B€ 2.16B€ 1.41B€ 1.41B
Total Debt€ 1.05B€ 979.61M€ 1.08B€ 516.45M€ 580.30M
Net Debt€ 848.88M€ 858.42M€ 921.66M€ 366.53M€ 419.98M
Total Liabilities€ 1.50B€ 1.47B€ 1.62B€ 880.34M€ 907.13M
Stockholders' Equity€ 694.38M€ 604.42M€ 539.21M€ 531.59M€ 497.32M
Cash Flow
Free Cash Flow€ 139.39M€ 163.14M€ 177.88M€ 249.52M€ 189.16M
Operating Cash Flow€ 181.51M€ 201.38M€ 219.42M€ 288.53M€ 250.37M
Investing Cash Flow€ -110.03M€ -29.61M€ -415.43M€ -99.01M€ -129.35M
Financing Cash Flow€ 13.32M€ -209.17M€ 204.54M€ -199.77M€ -80.98M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

Income Statement >

Dermapharm Holding SE Debt to Assets

Balance Sheet >

Dermapharm Holding SE Cash Flow

Cash Flow >

Dermapharm Holding SE Forecast EPS vs Actual EPS

Earnings >